Similar articles

• Augmentation of cognitive behavioral therapy with pharmacotherapy.

  Ganasen KA, Ipser JC, Stein DJ. Ganasen KA, et al. Psychiatr Clin North Am. 2010 Sep;33(3):687-99. doi: 10.1016/j.psc.2010.04.008. Psychiatr Clin North Am. 2010. PMID: 20599140 Review.
• Role of the NMDA receptor in cognitive deficits, anxiety and depressive-like behavior in juvenile and adult mice after neonatal dexamethasone exposure.

  Li SX, Fujita Y, Zhang JC, Ren Q, Ishima T, Wu J, Hashimoto K. Li SX, et al. Neurobiol Dis. 2014 Feb;62:124-34. doi: 10.1016/j.nbd.2013.09.004. Epub 2013 Sep 17. Neurobiol Dis. 2014. PMID: 24051277
• Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.

  Rezvanfard M, Zarrindast MR, Bina P. Rezvanfard M, et al. Pharmacology. 2009;84(6):356-66. doi: 10.1159/000256666. Epub 2009 Nov 11. Pharmacology. 2009. PMID: 19907194
• Differential Effects of D-Cycloserine and ACBC at NMDA Receptors in the Rat Entorhinal Cortex Are Related to Efficacy at the Co-Agonist Binding Site.

  Lench AM, Robson E, Jones RS. Lench AM, et al. PLoS One. 2015 Jul 20;10(7):e0133548. doi: 10.1371/journal.pone.0133548. eCollection 2015. PLoS One. 2015. PMID: 26193112 Free PMC article.
• Neurobiology of anxiety disorders and implications for treatment.

  Garakani A, Mathew SJ, Charney DS. Garakani A, et al. Mt Sinai J Med. 2006 Nov;73(7):941-9. Mt Sinai J Med. 2006. PMID: 17195879 Review.